{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:50:46Z","timestamp":1782255046878,"version":"3.54.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>IgM nephropathy is a rare disease with variable clinical presentations and is an unusual cause of nephrotic syndrome. Histopathological findings typically include mesangial hypercellularity with IgM and complement deposition, though the spectrum may range from normal glomeruli through to focal and segmental glomerulosclerosis. Thromboembolism is a well recognised complication of nephrotic syndrome, but cerebral venous sinus thrombosis is rarely described.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>This is the case of a 23-year-old male presenting with the nephrotic syndrome, whose initial renal biopsy was consistent with minimal change disease. Complete remission was achieved with prednisone, however multiple relapses and steroid dependence prompted re-biopsy, the results of which were more consistent with IgM nephropathy. His last relapse was complicated by cerebral venous sinus thrombosis. He then received rituximab and a weaning course of prednisone to again enter remission.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This case highlights the need to consider IgM nephropathy in the differential diagnosis of nephrotic syndrome. Additionally, it emphasises the risk of thrombosis in patients with severe nephrosis.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12882-020-02048-5","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T14:02:48Z","timestamp":1599487368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["IgM nephropathy complicated by cerebral venous sinus thrombosis: a case study"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1273-1236","authenticated-orcid":false,"given":"Elizabeth","family":"Downie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Diep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagendraprasad","family":"Sungala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,7]]},"reference":[{"issue":"1","key":"2048_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12882-019-1528-2","volume":"20","author":"KS Park","year":"2019","unstructured":"Park KS, Kang EW, Kie JH. A case report of immunoglobulin M nephropathy manifesting as crescentic glomerulonephritis and nephrotic syndrome in an adult. BMC Nephrol. 2019;20(1):335.","journal-title":"BMC Nephrol"},{"issue":"5","key":"2048_CR2","first-page":"823","volume":"32","author":"TM Connor","year":"2017","unstructured":"Connor TM, Aiello V, Griffith M, Cairns T, Roufosse CA, Cook HT, Pusey CD. The natural history of immunoglobulin M nephropathy in adults. Nephrol Dial Transplant. 2017;32(5):823\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"2048_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.5812\/numonthly.2805","volume":"4","author":"M Mubarak","year":"2012","unstructured":"Mubarak M, Kazi JI. IgM nephropathy revisited. Nephro-Urol Mon. 2012;4(4):603\u20138.","journal-title":"Nephro-Urol Mon"},{"issue":"5","key":"2048_CR4","first-page":"610","volume":"38","author":"AH Cohen","year":"1978","unstructured":"Cohen AH, Border WA, Glassock RJ. Nephrotic syndrome with glomerular mesangial IgM deposits. Lab Investig. 1978;38(5):610\u20139.","journal-title":"Lab Investig"},{"issue":"2","key":"2048_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/ajkd.2003.50042","volume":"41","author":"J Myllymaki","year":"2003","unstructured":"Myllymaki J, Saha H, Mustonenen J, Helin H, Pasternack A. IgM nephropathy: clinical picture and log-term prognosis. Am J Kidney Dis. 2003;41(2):343\u201350.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2048_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/2229-5151.183019","volume":"6","author":"HF Al-Azzawi","year":"2016","unstructured":"Al-Azzawi HF, Obi OC, Safi J, Song M. Nephrotic syndrome induced thromboembolism in adults. Int J Crit Ill Inj Sci. 2016;6(2):85\u20138.","journal-title":"Int J Crit Ill Inj Sci"},{"issue":"2","key":"2048_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.107.716951","volume":"117","author":"BK Mahmoodi","year":"2008","unstructured":"Mahmoodi BK, ten Kate MK, Waanders F, et al. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation. 2008;117(2):224\u20133.","journal-title":"Circulation."},{"issue":"2","key":"2048_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/ki.1994.274","volume":"46","author":"TJ Rabelink","year":"1994","unstructured":"Rabelink TJ, Zwaginga JJ, Koomans HA, Sixma JJ. Thrombosis and hemostasis in renal disease. Kidney Int. 1994;46(2):287\u201396.","journal-title":"Kidney Int"},{"key":"2048_CR9","volume-title":"UpToDate. [database on the internet]","author":"RJ Falk","year":"2018","unstructured":"Falk RJ, Merkel PA. Clinical spectrum of antineutrophil cytoplasmic autoantibodies. In: Lam AQ, Ramirez Curtis M, editors. UpToDate. [database on the internet]. Waltham: UpToDate; 2018. [updated 2020 June 18, cited 2020 April 21]. Available from: https:\/\/www.uptodate.com.acs.hcn.com.au\/contents\/clinical-spectrum-of-antineutrophil-cytoplasmic-autoantibodies?search=Clinical%20spectrum%20of%20antineutrophil%20cytoplasmic%20autoantibodies&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1."},{"issue":"1","key":"2048_CR10","first-page":"21","volume":"39","author":"HK Bhasin","year":"1978","unstructured":"Bhasin HK, Abuelo JG, Nayak R, Esparza AR. Mesangial proliferative glomerulonephritis. Lab Investig. 1978;39(1):21\u20139.","journal-title":"Lab Investig"},{"key":"2048_CR11","volume-title":"UpToDate [database on the internet]","author":"A Meyrier","year":"2019","unstructured":"Meyrier A, Radhakrishnan J. Treatment of minimal change disease in adults. In: Lam AQ, editor. UpToDate [database on the internet]. Waltham: UpToDate; 2019. [updated 2019 October 27, cited 2020 February 4]. Available from: https:\/\/www.uptodate.com.acs.hcn.com.au\/contents\/treatment-of-minimal-change-disease-in-adults?search=Treatment%20of%20minimal%20change%20disease%20in%20adults&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1."},{"issue":"1","key":"2048_CR12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4103\/1319-2442.252917","volume":"30","author":"FA Ahmed","year":"2019","unstructured":"Ahmed FA, El-Meanawy A. IgM nephropathy - successful treatment with rituximab. Saudi J Kidney Dis Transpl. 2019;30(1):235\u20138.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"6","key":"2048_CR13","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1053\/j.ajkd.2008.10.038","volume":"53","author":"MGH Betjez","year":"2009","unstructured":"Betjez MGH, Roodnat JI. Resolution of IgM nephropathy after rituximab treatment. Am J Kidney Dis. 2009;53(6):1059\u201362.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2048_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/00000441-200607000-00006","volume":"332","author":"SS Nandish","year":"2006","unstructured":"Nandish SS, Khardoris R, Elamin EM. Transient ischaemic attack and nephrotic syndrome: case report and review of literature. Am J Med Sci. 2006;332(1):32\u20135.","journal-title":"Am J Med Sci"},{"issue":"9","key":"2048_CR15","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1161\/STROKEAHA.116.013617","volume":"47","author":"S Devasagayam","year":"2016","unstructured":"Devasagayam S, Wyatt B, Leyden J, Kleinig T. Cerebral venous sinus thrombosis incidence is higher than previously thought: a retrospective population-based study. Stroke. 2016;47(9):2180\u20132.","journal-title":"Stroke."},{"issue":"3","key":"2048_CR16","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/01.STR.0000117571.76197.26","volume":"35","author":"JM Ferro","year":"2004","unstructured":"Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the international study on cerebral vein and Dural sinus thrombosis (ISCVT). Stroke. 2004;35(3):664\u201370.","journal-title":"Stroke."},{"key":"2048_CR17","volume-title":"UpToDate [database on the internet]","author":"JM Ferro","year":"2019","unstructured":"Ferro JM, Canhao P. Cerebral venous thrombosis: Etiology, clinical features, and diagnosis. In: Dashe JF, editor. UpToDate [database on the internet]. Waltham: UpToDate; 2019. [updated 2020 May 1, cited 2020 May 20]. Available from: https:\/\/www.uptodate.com.acs.hcn.com.au\/contents\/cerebral-venous-thrombosis-etiology-clinical-features-and-diagnosis?search=Cerebral%20venous%20thrombosis:%20Etiology,%20clinical%20features,%20and%20diagnosis&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1."},{"key":"2048_CR18","volume-title":"UpToDate [database on the internet]","author":"JM Ferro","year":"2020","unstructured":"Ferro JM, Canhao P. Cerebral venous thrombosis: Treatment and prognosis. In: Dashe JF, editor. UpToDate [database on the internet]. Waltham: UpToDate; 2020. [updated 2020 May 13, cited 2020 May 20]. Available from: https:\/\/www.uptodate.com.acs.hcn.com.au\/contents\/cerebral-venous-thrombosis-treatment-and-prognosis?search=cerebral%20venous%20sinus%20thrombosis:%20treatment%20and%20prognosis&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1."},{"issue":"830","key":"2048_CR19","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1136\/pgmj.70.830.905","volume":"70","author":"IH Fahal","year":"1994","unstructured":"Fahal IH, McClelland P, Hay CRM, Bell GM. Arterial thrombosis in the nephrotic syndrome. Postgrad Med J. 1994;70(830):905\u20139.","journal-title":"Postgrad Med J"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02048-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-02048-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02048-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T23:18:17Z","timestamp":1630970297000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-02048-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,7]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2048"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-02048-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,7]]},"assertion":[{"value":"5 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No ethics approval was required as this is a case study. Written and verbal consent was obtained from the patient.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written and verbal consent was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"390"}}